| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/30/2011 | US20110160231 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof |
| 06/30/2011 | US20110160215 Substituted Triazolo-Pyrazine Compounds |
| 06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 06/30/2011 | US20110160197 Substituted Indoles and a Method for the Production and Use Thereof |
| 06/30/2011 | US20110160193 New Benzothiazinone Derivatives and Their Use as Antibacterial Agents |
| 06/30/2011 | US20110160188 Paramyxovirus family inhibitors and methods of use thereof |
| 06/30/2011 | US20110160178 Heterosubstituted n-thiolated beta-lactam compounds and methods of use |
| 06/30/2011 | US20110160177 Novel carbapenem derivatives |
| 06/30/2011 | US20110160175 18,21-Didesoxymacbecin Derivatives for the Treatment of Cancer |
| 06/30/2011 | US20110160172 Fluoroquinolone derivatives for ophthalmic applications |
| 06/30/2011 | US20110160166 Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues |
| 06/30/2011 | US20110160165 7-Pyrazolyl Tetracycline Compounds and Methods of Use Thereof |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160156 Pharmaceutical Composition for the Eradication of Helicobacter Pylori and Preparation Method Thereof |
| 06/30/2011 | US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device |
| 06/30/2011 | US20110160127 Prodrugs of Neuraminidase Inhibitors |
| 06/30/2011 | US20110160126 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 06/30/2011 | US20110160125 Method and culture medium for enhanced detection of mycobacterium |
| 06/30/2011 | US20110160124 Antimicrobial protein compositions and production therefor from marine bacteria |
| 06/30/2011 | US20110160123 Targeting the efflux systems of mycobacterium tuberculosis |
| 06/30/2011 | US20110160122 Polypeptides having Antimicrobial Activity and Polynucleotides Encoding Same |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110160118 Methods and compositions for treating oral and esophageal lesions |
| 06/30/2011 | US20110159116 Biocompatible materials for medical devices |
| 06/30/2011 | US20110159108 Germ guard lid and methods for using germ guard lid |
| 06/30/2011 | US20110159106 Dermatological compositions containing an association of peroxidized lipids and zinc, and uses thereof in particular in the treatment of herpes |
| 06/30/2011 | US20110159104 Microemulsion |
| 06/30/2011 | US20110159096 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative For Pharmaceutical Use, and The Use Of a 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative With Substantially Undefined Crystal Shape For Preparing Said 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative |
| 06/30/2011 | US20110159092 Extended release pharmaceutical composition comprising linezolid and process for preparing the same |
| 06/30/2011 | US20110159091 Rapidly dispersible vaginal tablet that provides a bioadhesive gel |
| 06/30/2011 | US20110159088 ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS |
| 06/30/2011 | US20110159083 Nanoparticles for protein drug delivery |
| 06/30/2011 | US20110159079 High Delivery Rates for Lipid Based Drug Formulations, and Methods of Treatment Thereof |
| 06/30/2011 | US20110159062 Antiseptic compositions and uses thereof |
| 06/30/2011 | US20110159049 Pharmaceutical composition |
| 06/30/2011 | US20110159047 Stable powder formulations of alum-adsorbed vaccines |
| 06/30/2011 | US20110159042 Pythium immunotherapy |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159040 Novel immunogens and methods for discovery and screening thereof |
| 06/30/2011 | US20110159039 Eliciting hcv-specific antibodies |
| 06/30/2011 | US20110159038 Drying process |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159033 West nile virus vaccine |
| 06/30/2011 | US20110159031 Vaccine to Influenza A Virus |
| 06/30/2011 | US20110159030 Mucosal combination vaccines for bacterial meningitis |
| 06/30/2011 | US20110159029 Measuring degree of polymerisation for meningococcal capsular saccharides that contain sialic acid |
| 06/30/2011 | US20110159027 S. agalactiae antigens i & ii |
| 06/30/2011 | US20110159026 Compositions and methods of enhancing immune responses to flagellated bacterium |
| 06/30/2011 | US20110159024 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
| 06/30/2011 | US20110159001 CROSS-NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES TO SARS-CoV AND METHODS OF USE THEREOF |
| 06/30/2011 | US20110159000 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/30/2011 | US20110158997 Single chain fragment variable antibody libraries and uses thereof |
| 06/30/2011 | US20110158985 Methods of preventing and treating rsv infections and related conditions |
| 06/30/2011 | US20110158984 Anti-orthopoxvirus recombinant polyclonal antibody |
| 06/30/2011 | US20110158974 Heterodimeric Meganucleases and Use Thereof |
| 06/30/2011 | US20110158957 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| 06/30/2011 | US20110158954 Method for producing gamma delta t cell population |
| 06/30/2011 | US20110158943 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 06/30/2011 | US20110158942 Diaryl ureas for treating virus infections |
| 06/30/2011 | US20110158941 Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/30/2011 | US20110158940 Samll molecule inhibitors for the treatment or prevention of dengue virus infection |
| 06/30/2011 | US20110158938 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonists / antagonists activity |
| 06/30/2011 | US20110158937 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 06/30/2011 | US20110158935 Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents |
| 06/30/2011 | US20110158917 Anti-viral tissue product with visual efficacy indicator |
| 06/30/2011 | US20110158916 Anti-viral tissue product with visual indicator |
| 06/30/2011 | US20110158909 Cationic Contrast Agents and Methods of Use Thereof |
| 06/30/2011 | US20110158908 Cyclosporin a-binding protein |
| 06/30/2011 | DE102009060175A1 Pyrrolo[2,3-d] pyrazin-7-yl-pyrimidin-Verbindungen Pyrrolo [2,3-d] pyrazin-7-yl-pyrimidine compounds |
| 06/30/2011 | DE102009060174A1 Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate Pyrrolopyridinyl-pyrimidin-2-yl-amine derivatives |
| 06/30/2011 | CA2785643A1 Highly permeating terbinafine formulation for treating onychomycosis |
| 06/30/2011 | CA2785329A1 Pyrrolo[2,3-d]pyrazin-7-ylpyrimidine compounds |
| 06/30/2011 | CA2784600A1 New inhibitors of cyclophilins and uses thereof |
| 06/30/2011 | CA2784547A1 Influenza targets |
| 06/30/2011 | CA2784447A1 Immunogenic compositions and related methods |
| 06/30/2011 | CA2784036A1 Analogues for the treatment or prevention of flavivirus infections |
| 06/30/2011 | CA2783955A1 Immunogenic compositions |
| 06/30/2011 | CA2783704A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | CA2781780A1 Novel antiviral compounds |
| 06/30/2011 | CA2780357A1 Extracts from kibdelos porangium as antibacterial agents |
| 06/29/2011 | EP2339344A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/29/2011 | EP2339011A1 West Nile virus and Dengue 4 virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 06/29/2011 | EP2339003A2 APO-2 ligand substitutional variants |
| 06/29/2011 | EP2338996A2 Methods and compositions for reducing viral genome amounts in a target cell |
| 06/29/2011 | EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies |
| 06/29/2011 | EP2338902A1 Klebsiella antigens |
| 06/29/2011 | EP2338894A1 Flavivirus fusion inhibitors |
| 06/29/2011 | EP2338522A1 Antitumoural therapies |
| 06/29/2011 | EP2338521A1 Lipopeptide- and lipoprotein-conjugates and its use |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/29/2011 | EP2338508A1 A rDEN3/4delta 30(ME), rDEN2/4delta30(ME) or rDEN1/4delta30(ME) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the TL2 stem-loop structure. |
| 06/29/2011 | EP2338499A1 5' triphosphate oligonucleotide induces anti-viral response |
| 06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 06/29/2011 | EP2337784A1 Macrocyclic compounds as hepatitis c virus inhibitors |
| 06/29/2011 | EP2337781A2 Anti-viral compounds to treat hcv infection |
| 06/29/2011 | EP2337578A2 Composition and methods for modulating toll-like receptor activity |
| 06/29/2011 | EP2337575A1 Methods of treatment using single doses of oritavancin |
| 06/29/2011 | EP2337574A2 Anti-fungal therapy |